Fundz

TIXiMED reported raising $550,000 in an initial SEC Form D filing, from an offering of $550,000

PRIVATENov 05, 2024

Amount Raised

$550,000

$550,000 per company press release (Dec 19, 2024)

Round Type

Seed

BirminghamHealthcare

Investors

The Leona M. And Harry B. Helmsley Charitable Trust

Quick answer

TIXiMED raised $550,000 in a Seed round, dated October 15, 2024. Investors: The Leona M. And Harry B. Helmsley Charitable Trust. TIXiMED is based in Birmingham, Alabama, United States.

How much did TIXiMED raise?
TIXiMED raised $550,000 in a Seed round on October 15, 2024.
Who invested in TIXiMED?
The Leona M. And Harry B. Helmsley Charitable Trust is named as investors in this round.
What does TIXiMED do?
TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes.
Where is TIXiMED based and how big is it?
TIXiMED is based in Birmingham, Alabama, United States.
Who are the decision-makers at TIXiMED?
Fundz holds 1 contact at TIXiMED. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as TIXiMED that raised within 45 days of this round, from Fundz verified event records.

  • Balanced Pharma raised $2M (Seed) on November 27, 2024.
  • Huxley Medical, Inc. raised $4.6M (Seed) on November 27, 2024.
  • Steel Therapeutics raised $2M (Seed) on November 27, 2024.
  • Yuvo, Inc. raised $8.2M on November 26, 2024.
  • Sirona Medical, Inc. raised $42M (Series C) on November 26, 2024.
  • VeraDermics raised $67M on November 25, 2024.

Who to call at TIXiMED, and when

A new round usually means TIXiMED is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TIXiMED raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TIXiMED, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TIXiMED. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TIXiMED

Location

1927 1ST AVENUE NORTH

Birmingham, Alabama, United States

About

TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes. TIXiMED is the exclusive license holder for the patent (composition of matter and method of use) surrounding TIX100, a novel small molecule that normalizes pancreatic beta cell TXNIP, a detrimental protein elevated in Type 1 and Type 2 diabetes. Increased TXNIP causes pancreatic islet dysfunction and death of insulin-producing beta cells and thereby contributes to the development and progression of diabetes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TIXiMED raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for TIXiMED's next move

See what Strategic adds

TIXiMED raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.